Around 20–40% of the general population are estimated to have insulin resistance—a condition where insulin begins to be less ...

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

One in three people who have a routine test during dental appointments are diagnosed with pre-diabetes or diabetes.

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...

But here's why you likely won't be seeing it in your doctor's office anytime soon.

Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.

Feb 20 (Reuters) - (Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here.) Diabetes ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.

When combined with clinical markers, smartwatch data was able to help detect insulin resistance with nearly 90 percent ...

Some surveys find that about 75% of U.S. adults have used supplements, while federal survey data shows that 58% used one in the past 30 days — but some groups should exercise caution, experts say.

Persistently high blood sugar levels can damage the delicate filtering units of the kidneys, eventually leading to diabetic kidney disease.

Doctors warn that subtle symptoms like fatigue, foamy urine, swelling or lower back pain may signal early kidney problems ...